FentaNYL Citrate Injectable Solution in 0 recalled over manufacturing violations
- Recall date
- April 1, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-1…
- Recall number
- D-0508-2026
- FDA classification
- Class II
- Brand / firm
- Wells Pharma of Houston LLC
- Sold / distributed
- U.S. Nationwide.
Why it was recalled
cGMP deviations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Get recall alerts
Free email alert whenever Wells Pharma of Houston LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wells Pharma of Houston LLC